VIP research explained

VIP Research: Structure and Laboratory Studies

VIP Research: Structure and Laboratory Studies

Research only. All AVM Labs USA products are sold strictly for laboratory research. Nothing on this page is medical advice, and nothing here describes use in humans or animals.

VIP is a 28-residue neuropeptide, one of the longer peptides in this catalogue, and one of the most often confused: its name is short, its sequence is long, and its records disagree on the form. This guide explains it the way the laboratory literature does: its molecular structure, how it is synthesized and characterized, and how to read the studies that mention it.

What VIP is, in laboratory terms

VIP is the vasoactive intestinal peptide, a 28-amino-acid neuropeptide of the secretin/glucagon peptide family. It was first isolated from porcine duodenum by Said and Mutt in 1970. The mature human peptide is UniProt P01282 residues 125–152. It is also catalogued under the name aviptadil for the synthetic form. In the literature it is identified by its receptors, VPAC1 and VPAC2, class B G-protein-coupled receptors — which is how research papers identify it.

The name “VIP” covers one full-length peptide, not a family of interchangeable fragments. A paper that says only “VIP” and gives no sequence has not identified which form was studied.

Molecular structure

The reported molecular identity of VIP, in its C-terminally amidated form, is:

  • A 28-amino-acid chain — His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn, written HSDAVFTDNYTRLRKQMAVKKYLNSILN in one-letter code.
  • A C-terminal amide (-NH2) — the final asparagine ends in an amide, not a free acid. This is the form described in the reference records below.
  • A molecular formula of C147H238N44O42S, with a molecular weight of approximately 3325.8 g/mol and a monoisotopic mass of 3323.76 Da.
  • CAS number 40077-57-4, the GSRS record for aviptadil.
  • One methionine residue — at position 17, the only sulfur-bearing residue in the chain, and the residue most susceptible to oxidation in analytical work. The chain has no cysteine residues and no intramolecular disulfide bonds.

At approximately 3325.8 Da, VIP is a large peptide for this catalogue, and that mass is the first identity check on a COA.

These are the structural facts a Certificate of Analysis verifies: the sequence, the 28 residues, the C-terminal amide, and the molecular weight.

VIP is not the free-acid form, and it is not a fragment

Three records for VIP are often confused, and the laboratory tells them apart by formula and mass alone:

  • VIP, amidated — C147H238N44O42S, approximately 3325.8 Da, CAS 40077-57-4. This is the form this post describes.
  • VIP, free acid — C147H237N43O43S, approximately 3326.8 Da, CAS 37221-79-7 in some supplier records (PubChem CID 16132300). Same 28 residues, a free carboxylic acid at the end instead of an amide — about one dalton heavier, with a different formula.
  • VIP fragments — such as VIP 1-11 or VIP 6-28, used as receptor-fragment tools. Shorter chains, different masses, different molecules.

Different termini, different lengths, different masses — which is why the formula and the molecular weight on the COA, not the short name alone, settle which form a lot contains.

How research peptides like VIP are made: solid-phase synthesis

Like most research peptides, VIP is produced by solid-phase peptide synthesis (SPPS):

  1. The first amino acid is anchored to a solid resin support.
  2. Amino acids are added one at a time, in the planned sequence, with the growing chain held on the resin.
  3. Protecting groups shield the parts of each amino acid that should not react yet, and are removed at the right step.
  4. The finished chain is cleaved from the resin, amidated at the C-terminus as specified, and purified.

The laboratory controls exactly the same variables as for a shorter chain: which amino acids, in which order, and with which stereochemistry. All 28 residues are the L-form, and that is part of the identity a COA verifies. Our post on peptide synthesis explains this method in detail.

How VIP is characterized: identity and purity

A research peptide is not defined by its name alone. In the laboratory it is defined by analytical data, typically:

  • Mass spectrometry (MS): confirms the molecular weight matches the intended form. For amidated VIP the observed mass must read approximately 3325.8 Da — not the 3326.8 Da of the free-acid form, and not the mass of a fragment.
  • High-performance liquid chromatography (HPLC): measures purity and reveals impurities, including deletion sequences, incomplete coupling products, oxidized methionine and deamidated asparagine from synthesis and handling.
  • Certificate of Analysis (COA): the laboratory document that reports those results for a specific batch.

When comparing research materials, the COA is the document that matters: same compound, different batch, different data. Our guide on how to read a peptide COA explains what each field on that document means.

How VIP is studied in the literature

Laboratory research on VIP takes several forms:

  • In vitro receptor assays: measurements of binding and activation at VPAC1 and VPAC2 in cell-based systems, where conditions are controlled and variables are isolated.
  • Structural and analytical studies: stability, solubility and degradation — how the peptide behaves in solution, at different temperatures, and over time, including methionine oxidation and asparagine deamidation.
  • Comparative studies: VIP measured alongside other members of the secretin/glucagon family, so that the 28-residue sequence can be distinguished from related peptides by sequence and mass.

The record is a laboratory record throughout: cell-based assays and analytical work, with the receptor family named as the identifier of the peptide.

Stability and handling in the laboratory

Peptides are sensitive molecules, and laboratory handling reflects that. The topics researchers document include storage temperature, protection from light and moisture, freeze–thaw cycles, and how long a prepared solution remains stable. Our posts on peptide storage and stability and on refrigeration and shipping cover this in detail.

How to read a VIP study

When you open a paper that mentions VIP, check four things first:

  1. What exactly was studied? The compound name, the sequence or identifier (HSDAVFTDNYTRLRKQMAVKKYLNSILN-NH2), and the source of the material — and whether the paper means the amidated form, the free-acid form, or a fragment.
  2. In what model? In vitro assay, or another setting — and what that model can and cannot show.
  3. At what scale? The number of samples, the controls used, and whether the result was reproduced.
  4. Who funded it, and where was it published? Peer review and disclosure are part of the evidence, not decoration.

For the general background, start with What Are Peptides?

Related research on this blog

  • What Are Peptides? — the general background for every post in this series: what-are-peptides

Glossary

  • Neuropeptide: a peptide studied in nervous-system signalling literature.
  • VPAC1 / VPAC2: the receptors named in the VIP literature.
  • C-terminal amide: a chain ending in -NH2 rather than a free carboxylic acid.
  • Deamidation: a chemical change at an asparagine residue, read in analytical data.
  • Methionine oxidation: a chemical change at a methionine residue, read in analytical data.
  • SPPS: solid-phase peptide synthesis, the standard laboratory method for building peptides.
  • HPLC: high-performance liquid chromatography, used to measure purity.
  • Mass spectrometry (MS): used to confirm molecular weight and identity.
  • COA: Certificate of Analysis, the batch document reporting analytical results.
  • In vitro: experiments outside a living organism, e.g. in cell culture.

Frequently asked questions (research framing)

Is VIP the same as aviptadil?
Aviptadil is the catalogue name for the synthetic form of VIP; the sequence and the amidated form are the same reference identity.

How is the amidated form different from the free-acid form?
The amidated form ends in -NH2 (C147H238N44O42S, approximately 3325.8 Da); the free-acid form ends in a free carboxylic acid (C147H237N43O43S, approximately 3326.8 Da).

What does a COA tell me?
It reports the analytical results — identity and purity — for one specific batch, measured by the laboratory that tested it. For VIP, the key identity checks are the 28-residue sequence, the C-terminal amide, and the molecular weight of approximately 3325.8 Da.

Where can I learn more?
Start with the posts linked above, and read the primary literature they cite.


Research only. AVM Labs USA products are for laboratory research use only.

Scroll to Top
header ´para el telefono

Welcome back to AVM Labs USA. Sign in below to access your account and continue shopping.

Don’t have an account yet?
Create your AVM Labs USA account before signing in.